Cyclobarbital
Cyclobarbital, also known as cyclobarbitone in some regions, is a barbiturate derivative used primarily as a sedative and hypnotic. It was first synthesized in the early 20th century and has been utilized in the treatment of insomnia and as a component in some anesthetic protocols. Like other barbiturates, cyclobarbital acts by enhancing the action of GABA (gamma-aminobutyric acid), a neurotransmitter that inhibits the activity of neurons, leading to sedation and hypnosis.
Chemical Properties
Cyclobarbital is chemically known as 5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid. It is a white, crystalline substance that is soluble in alcohol and ether but relatively insoluble in water. Its molecular formula is C12H16N2O3.
Pharmacology
The pharmacological action of cyclobarbital involves the potentiation of GABAergic neurotransmission, which in turn leads to the depression of the central nervous system (CNS). This results in sedative, hypnotic, and anticonvulsant effects. Cyclobarbital's onset of action is relatively rapid, and its effects can last for several hours, making it effective for the induction of sleep and maintenance of sedation.
Clinical Uses
Cyclobarbital has been used for the treatment of insomnia and as a pre-anesthetic medication to induce sedation before surgical procedures. However, its use has declined over the years due to the development of newer drugs with fewer side effects and lower risk of dependence.
Side Effects and Risks
The use of cyclobarbital, like other barbiturates, is associated with a range of side effects including drowsiness, dizziness, and impaired coordination. Long-term use or abuse can lead to dependence and withdrawal symptoms upon cessation. Overdose can result in severe respiratory depression, coma, and death. Due to these risks, cyclobarbital is now less commonly prescribed, with preference given to benzodiazepines and other non-barbiturate sedatives.
Regulation and Control
Cyclobarbital is classified as a controlled substance in many countries, subject to regulations that govern its prescription and distribution. Its potential for abuse and dependence has led to strict controls to minimize misuse.
Conclusion
While cyclobarbital played an important role in the management of insomnia and as a sedative in the past, its use today is limited due to the availability of safer alternatives. Its history in medicine, however, provides valuable insights into the development of sedative-hypnotic drugs and the evolution of pharmacotherapy in sleep disorders.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD